title: The Association of Cancer Physicians responds to "Cancer drugs, survival, and ethics".
authors.affiliation: Bristol Cancer Institute, Bristol Haematology and Oncology Centre, Bristol BS2 8ED, UK.
authors.forename: Adam
authors.initials: A
authors.lastname: Dangoor
authors.affiliation: Huddersfield Royal Infirmary, Huddersfield, UK.
authors.forename: Johnathan
authors.initials: J
authors.lastname: Joffe
authors.affiliation: Imperial College, London, UK.
authors.forename: Adam
authors.initials: A
authors.lastname: Januszewski
authors.affiliation: Guy's and St Thomas' Hospital, London, UK.
authors.forename: Janine
authors.initials: J
authors.lastname: Mansi
authors.affiliation: Royal Marsden Hospital, London, UK.
authors.forename: David
authors.initials: D
authors.lastname: Cunningham
authors.affiliation: St James's University Hospital, Leeds, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Selby
mesh_terms: D000970:Antineoplastic Agents; D032781:Codes of Ethics; D004989:Ethics; D004992:Ethics, Medical; D006801:Humans; D009369:Neoplasms; D010820:Physicians
chemical_list: D000970:Antineoplastic Agents